Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-EN
Language English English
Date Updated 2022-10-01 2022-09-30
Drug Identification Number 02359499 02359499
Brand name MOVIPREP MOVIPREP
Common or Proper name Macrogol 3350, Sodium sulphate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid, Sodium ascorbate Macrogol 3350, Sodium sulphate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid, Sodium ascorbate
Company Name ARALEZ PHARMACEUTICALS CANADA INC ARALEZ PHARMACEUTICALS CANADA INC
Ingredients ASCORBIC ACID SODIUM ASCORBATE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM SULFATE ANHYDROUS POLYETHYLENE GLYCOL 3350 ASCORBIC ACID SODIUM ASCORBATE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM SULFATE ANHYDROUS POLYETHYLENE GLYCOL 3350
Strength(s) 4.7G 5.9G 1.015G 2.691G 7.5G 100G 4.7G 5.9G 1.015G 2.691G 7.5G 100G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration ORAL ORAL ORAL ORAL
Packaging size cartons containing 2 sachets A and 2 sachets B cartons containing 2 sachets A and 2 sachets B
ATC code A06AD A06AD
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-08-10 2022-08-10
Estimated end date
Actual end date 2022-09-30 2022-09-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments